Venture Leaders Biotech 2022
The Venture Leaders – the members of the Swiss National Startup Team – have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The Venture Leaders’ startup development program is specifically structured to help them achieve these goals. This intense journey offers 10 selected entrepreneurs an accelerated learning curve and a solid network through their exchanges with their peers in the team, as well as market exposure, feedback from investors and experts, and hands-on business development.
Venture Leaders Life Sciences alumni comprise high-flying startups such as Covagen (acquired by Johnson&Johnson), Redbiotec (partly acquired by Pfizer), KB Medical(acquired by Globus Medical), SimplicityBio (acquired by Precision for Medicine), AMAL Therapeutics (acquired by Boehringer Ingelheim) and Interax Biotech (Seed round with US investors met during the roadshow). Following these great success stories, Medtech and Biotech now have separate Venture Leaders programs, catering perfectly to the needs of entrepreneurial teams in the fields.
Read About, How to Manage the Risk for your Business
Eligibility
Venture Leaders Biotech 2022 invites entrepreneurs.
Benefits
- Biz Dev
- Fundraising
- Networking
- International
Application process
For more Interesting Content and other Opportunities Visit and Follow/Like Us On Facebook, Twitter, LinkedIn, and Instagram
Fee information: